Bernd Montag, Ph.D., has been CEO of Siemens Healthineers since February 2015. As of March 2018, the company is listed on the Frankfurt Stock Exchange as Siemens Healthineers AG (SHL). Three months after its stock market debut, Siemens Healthineers entered the technology index TecDAX and in September that year Deutsche Börse also included the company in the mid-cap index MDAX.
Bernd Montag joined Siemens in 1995. He held positions in corporate quality management and sales in the hearing aid division before moving to imaging systems in 1999, where he served as a product manager for computed tomography and as the head of marketing for magnetic resonance business. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the Imaging & Therapy Division, which combined the overall business of diagnostic imaging and image-guided therapies.
Bernd Montag completed his studies in Physics at the Friedrich-Alexander-University, Erlangen-Nuremberg, and earned a Ph.D. in theoretical multi-particle physics. He was born in Munich, Germany, in 1969.